nicolas fulpius brings several years of experience in the private equity and venture capital industry. From 2005 to 2010 he was a managing partner of affentranger associates. He is today CEO of Veltigroup, a subsidiary of Swisscom, and the acting Chairman of the board of inflaRx. His prior assignments include multiple chairman positions (SELFRAG, SIRS-Lab, Dunes Technologies). From 2001 to 2005 he was Investment Director at Ultreia Capital, a venture company focusing on biotech and acted as Private Equity Portfolio Manager for the LODH Immunology Fund, a fund specializing in the life sciences industry.¬†
nicolas fulpius holds a MBA (HSG lic. oec.) from the University of St. Gall (Switzerland) and a¬†MS¬†in Engineering from Stanford University (USA).